Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia 42Leukemia, Lymphocytic, Chronic, B-Cell 41Lymphoma 30Myelodysplastic Syndromes 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 18Hodgkin Disease 18Leukemia, Myeloid, Acute 17Multiple Myeloma 16Myeloproliferative Disorders 14Lymphoma, Mantle-Cell 10Lymphoma, Follicular 10Neoplasms, Plasma Cell 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Congenital Abnormalities 9Lymphoma, T-Cell, Peripheral 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Hematologic Neoplasms 8Burkitt Lymphoma 8Anemia, Aplastic 8Waldenstrom Macroglobulinemia 7Recurrence 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Large-Cell, Immunoblastic 7Primary Myelofibrosis 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Myeloid, Accelerated Phase 6

Interventions

fludarabine phosphate 4fludarabine 4Cyclophosphamide 4Thiotepa 3Melphalan 3Whole-Body Irradiation 2Tacrolimus 2Surveys and Questionnaires 2Busulfan 2Alemtuzumab 2thymoglobulin 1Rituximab 1Registries 1Range of Motion, Articular 1Protease Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Interviews as Topic 1Imagery, Psychotherapy 1Holistic Health 1Erythrocyte Count 1Dexamethasone 1Clofarabine 1Bortezomib 1Blood Transfusion 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Anemia, Sickle Cell × Alemtuzumab × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡